| ¿µ¹® | permeability | ÇÑ±Û | Åõ°ú¼º |
|---|---|---|---|
| ¼³¸í | ¾î¶² ¹°Áú°è³ª ±¸Á¶¿¡ ¾×ü³ª ±âü µîÀÇ È®»êÀÌ ÀÖ´Â °æ¿ì¿¡ ±× ±¸Á¶°¡ È®»ê¼º ¹°ÁúºÐÀÚÀÇ Åë°ú³ª ħÀÔÀ» Çã¿ëÇÏ´Â ¼ºÁú. »ý¹°ÇÐÀûÀ¸·Î´Â ƯÈ÷ ¼¼Æ÷¸·À» ºñ·ÔÇÑ ¿©·¯ »ýüÀÇ ¸·±¸Á¶°¡ °¡Áö´Â Åõ°ú¼ºÀÌ Áß¿äÇÏ´Ù. ÀÌ »ýü¸·ÀÇ ´ëºÎºÐÀº ¿ë¸Å³ª ÀϺÎÀÇ ÇÑÁ¤µÈ ¿ëÁú ºÐÀÚ¸¸À» Åë°ú½ÃŰ±â ½¬¿î ¹ÝÅõ¸·À» °¡Áö¸ç, ÀÌ ¼ºÁúÀº ±× »ýü¸·ÀÌ »ì¾Æ ÀÖ´Â »óÅ¿¡¼¸¸ À¯ÁöµÈ´Ù. »ýü¸·ÀÇ Åõ°ú¼ºÀº ±× ¸·À» Áö³ª¼ ÀϾ´Â ¿©·¯ °¡Áö ¹°ÁúÀÇ À̵¿¿¡ ±íÀº °ü°è°¡ ÀÖ´Ù. »ïÅõ¾Ð¿¡ ÀÇÇÑ ´Ü¼øÇÑ È®Àå¿¡ ÁÖ·Î ±âÀÎÇÏ´Â ¼öµ¿ÀûÀÎ °æ¿ì·ÎºÎÅÍ ¿°·ù-Æ÷µµ´ç-¾Æ¹Ì³ë»ê µîÀÇ Èí¼ö ¶§ ¿¡³ÊÁö¸¦ ÇÊ¿ä·Î ÇÏ´Â ´Éµ¿Àû ¼ö¼Û±îÁö ¿©·¯ °¡Áö°¡ ÀÖ´Ù. ¶ÇÇÑ ºÐºñ-Èí¼ö-¹èÃâ, ¸·ÀÇ ÈïºÐ¼º µî ¼ö¸¹Àº Áß¿äÇÑ »ý¸®Çö»óÀÇ ¿äÀÎÀÌ´Ù. |
||
| ¿µ¹® | rheumatoid factor | ÇÑ±Û | ·ù¸¶Æ¼½º ÀÎÀÚ |
|---|---|---|---|
| ¼³¸í | IgGÀÇ FcºÎÀ§¿¡ ÀÖ´Â Ç׿ø°áÁ¤ÀÎÀÚ¿¡ ´ëÇÑ Ç×ü·Î¼ ÀüÇüÀûÀÎ ¶Ç´Â È®½ÇÇÑ ·ù¸¶Æ¼½º°üÀý¿°(rheumatoid arthritis) ȯÀÚÀÇ 80%¿¡¼ ¹ß°ßµÈ´Ù. ·ù¸¶Æ¼½º ÀÎÀÚ´Â IgM, IgG, IgAÁß Çϳª°¡ µÉ ¼ö ÀÖÀ¸³ª ÁÖ·Î IgMÀÌ´Ù. ¼Ò¾Æ·ù¸¶Æ¼½º°üÀý¿°(juvenile rheumatoid arthritis: ¼Ò¾Æ±â¿¡ ¹ß»ýÇÏ´Â ·ù¸¶Æ¼½º°üÀý¿°)À» ºñ·ÔÇÑ, ´Ù¸¥ °áÇÕÁ¶Á÷º´À̳ª °¨¿°º´¿¡µµ ³ªÅ¸³¯ ¼ö ÀÖ´Ù |
||
| ¿µ¹® | growth factor | ÇÑ±Û | ¼ºÀåÀÎÀÚ |
|---|---|---|---|
| ¼³¸í | ¼¼Æ÷ÀÇ ºÐÈ ¹× ¼ºÀå¿¡ °ü¿©ÇÏ´Â ´Ü¹éÁú. ¼ºÀåÀÎÀÚ´Â Á¤»ó ¼¼Æ÷Áֱ⿡ ÇʼöÀûÀ̱⠶§¹®¿¡ µ¿¹°ÀÇ »ý¸í¿¡ Áß´ëÇÑ ¿ä¼Ò°¡ µÈ´Ù. ¹«¾ùº¸´Ùµµ ¼ºÀåÀÎÀڴ žÆÀÇ ¹ßÀ°À» Á¶Á¤Çϰí Á¶Á÷ÀÇ À¯Áö ¹× º¸¼ö¿¡ Áß´ëÇÑ ¿ªÇÒÀ» Çϸç, Ç÷±¸ÀÇ »ý¼ºÀ» ÀÚ±ØÇÑ´Ù. ¶ÇÇÑ ¾ÏÀÇ ÁøÇà°úÁ¤¿¡µµ °ü¿©ÇÑ´Ù. |
||
| ¿µ¹® | risk factor | ÇÑ±Û | À§ÇèÀÎÀÚ |
|---|---|---|---|
| ¼³¸í | ±¹Á¦¹æ»ç¼±¹æÈ£À§¿øÈ¸(ICRP)°¡ 1977³â ±Ç°í¿¡¼ ¹æ»ç¼±¹æÈ£ÀÇ ¸ñÀûÀ¸·Î äÅÃÇÑ Áö¼ö·Î, ´ÜÀ§¼±·®(1 Sv)´ç È®·üÀû ¿µÇâÀÇ ¹ß»ýÈ®·üÀ» ÃßÁ¤ÇÏ¿© ³ªÅ¸³½ °ÍÀÌ´Ù. »ý½Ä¼± ¼±·®¿¡ ´ëÇÑ À¯ÀüÀû¿µÇâÀÇ ¹ß»ý·ü(4¡¿10£3/Sv)À̳ª Àû»ö°ñ¼ö¼±·®¿¡ ´ëÇÑ ¹éÇ÷º´ ¹ß»ý·ü(2¡¿10£3/Sv)µî ¿Ü¿¡ »À, ÇãÆÄ, °©»ó»ù, Á¥»ù, ±âŸ Á¶Á÷ÀÇ À§ÇèÁö¼ö¸¦ ÃøÁ¤ÇÏ¿©, È®·üÀû ¿µÇâÀÇ Àü½Å¿¡ ÀÖ¾î¼ Ä¡»çÀ§ÇèÁö¼öÀÇ Çհ踦 16.5¡¿10£3/Sv·Î ÇÏ¿´´Ù. ±×ÈÄ ICRP´Â 1990³â ±Ç°í¿¡¼ ´ë»óÀÌ µÇ´Â Á¶Á÷°ú Àå±â¸¦ Ãß°¡Çϰí, ¼öÄ¡ °³Á¤À» ÇÏ¸é¼ ¸íεµ °¢¸ñÀûÈ®·üÁö¼ö¶ó°íÇÏ¿´´Ù. ÀÌ ±Ç°í¿¡ ÀÇÇϸé, Ä¡»çÀû È®·üÀû ¿µÇâÀÇ È®·üÁö¼öÀÇ ÇÕ°è´Â, ÀϹÝÀο¡ ÀÖ¾î 60.0¡¿10£3/SvÀÌ´Ù. |
||
| PF | pair feeding; peak flow; perfusion fluid; pericardial fluid; periosteal fibroblast; peritoneal fluid... |
|---|---|
| CF | calcaneal fibular [ligament]; calcium leucovorin; calf blood flow; calibration factor; cancer-free; ... |
| HPE | hepatic portoenterostomy; high-permeability edema; history and physical examination; holoprosencepha... |
| EF | ectopic focus; edema factor; ejection fraction; elastic fibril; electric field; elongation factor; e... |
| PAF | paroxysmal atrial fibrillation; peroxisomal assembly factor; phosphodiesterase-activating factor; pl... |
| VEGF/VPF | Vascular endothelial growth factor/ vascular permeability factor |
|---|---|
| VPF/VEGF | Vascular permeability factor/vascular endothelial growth factor |
| PF | Permeability factor |
| VPF | VEGF)/vascular permeability factor |
| VPF | Vascular permeability factor |
IGF-II : insulin like growth factor-IIÀÇ ¾àÀÚ. ¸¹Àº Àå±â¿Í Á¶Á÷¿¡ ÀÛ¿ëÇÏ¿© ´Ü¹é ÇÕ¼º°ú DNA, RNAÀÇ ÇÕ¼ºÀ» Áõ°¡½ÃÄÑ ¼¼Æ÷ÀÇ ¼ö¿Í ¾çÀ» Áõ°¡
| capillary permeability factor | A mixture of bioflavonoids extracted from plants (especially citrus fruits). It reduces the permeability and fragility of capillaries and is useful in the treatment of certain cases of purpura that are resistant to vitamin C therapy. See: hesperidin, quercetin, rutin. Synonym: capillary permeability factor, citrin, permeability vitamin. (05 Mar 2000) |
|---|---|
| Duran-Reynals permeability factor | <enzyme> Enzyme that degrades hyaluronic acid, found in lysosomes. (18 Nov 1997) |
| lymph node permeability factor | A substance, released by lymphocytes when stimulated or damaged, that increases capillary permeability and the accumulation of mononuclear cells. (05 Mar 2000) |
| capillary permeability | Property of blood capillary walls that allows for the selective exchange of substances. Small lipid-soluble molecules such as carbon dioxide and oxygen move freely by diffusion. Water and water-soluble molecules cannot pass through the endothelial walls and are dependent on microscopic pores. These pores show narrow areas (tight junctions) which may limit large molecule movement. (12 Dec 1998) |
| cell membrane permeability | A quality of cell membranes which permits the passage of solvents and solutes into and out of cells. (12 Dec 1998) |
| permeability | The property or state of being permeable. (18 Nov 1997) |
| permeability coefficient | A coefficient associated with simple diffusion through a membrane that is proportional to the partition coefficient and the diffusion coefficient and inversely proportional to membrane thickness. (05 Mar 2000) |
| permeability constant | A measure of the ease with which an ion can cross a unit area of membrane driven by a 1.0 m difference in concentration; usually expressed in centimeters per second. Compare: permeability coefficient. (05 Mar 2000) |
| permeability theory of narcosis | That the permeability of the cell membrane is decreased by narcotic concentrations of aliphatic and other central nervous system depressants. (05 Mar 2000) |
| permeability vitamin | A mixture of bioflavonoids extracted from plants (especially citrus fruits). It reduces the permeability and fragility of capillaries and is useful in the treatment of certain cases of purpura that are resistant to vitamin C therapy. See: hesperidin, quercetin, rutin. Synonym: capillary permeability factor, citrin, permeability vitamin. (05 Mar 2000) |
| soil permeability | The ease with which gases, liquids or plant roots penetrate or pass through a layer of soil. (09 Oct 1997) |
| dental enamel permeability | <dentistry> The property of dental enamel to permit passage of light, heat, gases, liquids, metabolites, mineral ions and other substances. It does not include the penetration of the dental enamel by microorganisms. (12 Dec 1998) |
| dentin permeability | The property of dentin that permits passage of light, heat, cold, and chemical substances. It does not include penetration by microorganisms. (12 Dec 1998) |
| accelerator factor | <chemical> Heat- and storage-labile plasma glycoprotein which accelerates the conversion of prothrombin to thrombin in blood coagulation. Factor v accomplishes this by forming a complex with factor xa, phospholipid, and calcium (prothrombinase complex). Deficiency of factor v leads to owren's disease. Chemical name: Blood-coagulation factor V (12 Dec 1998) |
| acetate replacement factor | <biochemistry> 1,2 dithiolane 3 valeric acid. Regarded as a coenzyme in the oxoglutarate dehydrogenase complex of the citric acid cycle. Involved generally in oxidative decarboxylations of _ keto acids. A growth factor for some organisms. (18 Nov 1997) |
| Duran-Reynals' permeability factor |
hyaluronidase.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|